Insmed
INSM
#1022
Rank
S$30.13 B
Marketcap
S$139.03
Share price
2.48%
Change (1 day)
59.25%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -S$1.55 Billion

According to Insmed's latest financial reports the company's current earnings are S$0.60 Billion. a decrease over its 2024 earnings that were of -S$1.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -S$1.53 Billion43.91%
2024 -S$1.06 Billion23.71%
2023 -S$0.86 Billion45.77%
2022 -S$0.59 Billion15.83%
2021 -S$0.51 Billion50.19%
2020 -S$0.34 Billion16.4%
2019 -S$0.3 Billion-23.9%
2018 -S$0.39 Billion59.35%
2017 -S$0.24 Billion8.52%
2016 -S$0.23 Billion47.25%
2015 -S$0.15 Billion34.53%
2014 -S$0.12 Billion58.83%
2013 -S$70.09 Million35.14%
2012 -S$51.87 Million-31.92%
2011 -S$76.19 Million854.92%
2010 -S$7.98 Million-105.22%
2009 S$0.15 B-905.06%
2008 -S$18.98 Million-27.31%
2007 -S$26.11 Million-62.41%
2006 -S$69.44 Million98.19%
2005 -S$35.04 Million0.03%
2004 -S$35.03 Million159.07%
2003 -S$13.52 Million-69.31%
2002 -S$44.05 Million
2000 -S$39.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.15 B-1,421.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
S$12.51 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.46 B-523.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-S$0.9 Billion-41.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$29.68 Million-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-S$2.41 Million-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA